All In MedTech

FDA Clearance Tracker · K251615

Aerogen Pro-X1 Controller System

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Sep 2, 2025 (this decision)Source: openFDAMethods & limitations

510(k)First of its product code

Decided

Sep 2, 2025

Substantially Equivalent

Time to decision

98 days

Received May 27, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K251615
Device name
Aerogen Pro-X1 Controller System
Applicant
Aerogen, Ltd.
Applicant location
Galway, IE
Received
May 27, 2025
Decided
Sep 2, 2025
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 868.5630

Every decision under product code SFP

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code SFP (Ventilator-Compatible Nebulizer).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Aerogen, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.